22.36 0.41 (1.87%) | 02-14 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 27.81 | 1-year : | 32.48 |
Resists | First : | 23.8 | Second : | 27.81 |
Pivot price | 22.67 ![]() |
|||
Supports | First : | 20.71 ![]() |
Second : | 18.8 ![]() |
MAs | MA(5) : | 22.21 ![]() |
MA(20) : | 22.48 ![]() |
MA(100) : | 17.37 ![]() |
MA(250) : | 24.47 ![]() |
|
MACD | MACD : | 0.8 ![]() |
Signal : | 1.1 ![]() |
%K %D | K(14,3) : | 24.4 ![]() |
D(3) : | 30.7 ![]() |
RSI | RSI(14): 60.4 ![]() |
|||
52-week | High : | 40.88 | Low : | 13.39 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PGNY ] has closed above bottom band by 38.4%. Bollinger Bands are 41.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 22.57 - 22.68 | 22.68 - 22.8 |
Low: | 21.66 - 21.77 | 21.77 - 21.89 |
Close: | 22.17 - 22.36 | 22.36 - 22.54 |
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Sat, 15 Feb 2025
PGNY - Progyny, Inc. Latest Stock News & Market Updates - StockTitan
Thu, 13 Feb 2025
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report - GlobeNewswire
Thu, 13 Feb 2025
Earnings Alert: Progyny Sets Date for 2024 Annual Results - Key Details for Investors - StockTitan
Sun, 09 Feb 2025
Vanderbilt University Purchases Shares of 14,730 Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
Tue, 28 Jan 2025
Game-Changing Parental Benefits Deal: Progyny Just Solved Working Parents' Biggest Challenge - StockTitan
Tue, 28 Jan 2025
Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump - GlobeNewswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Healthcare Information Services
|
|
Shares Out | 85 (M) |
Shares Float | 73 (M) |
Held by Insiders | 7.3 (%) |
Held by Institutions | 108 (%) |
Shares Short | 11,530 (K) |
Shares Short P.Month | 12,200 (K) |
EPS | 0.6 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 4.92 |
Profit Margin | 5 % |
Operating Margin | 4.3 % |
Return on Assets (ttm) | 5.9 % |
Return on Equity (ttm) | 12 % |
Qtrly Rev. Growth | 2 % |
Gross Profit (p.s.) | 2.89 |
Sales Per Share | 13.38 |
EBITDA (p.s.) | 0.8 |
Qtrly Earnings Growth | -31.3 % |
Operating Cash Flow | 165 (M) |
Levered Free Cash Flow | 145 (M) |
PE Ratio | 37.26 |
PEG Ratio | 0 |
Price to Book value | 4.54 |
Price to Sales | 1.67 |
Price to Cash Flow | 11.56 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |